miRNAs调节食管癌放疗敏感性分子机制研究及预测疗效模型的建立

基本信息
批准号:81472791
项目类别:面上项目
资助金额:72.00
负责人:骆爱萍
学科分类:
依托单位:中国医学科学院肿瘤医院
批准年份:2014
结题年份:2018
起止时间:2015-01-01 - 2018-12-31
项目状态: 已结题
项目参与者:马刚,井超,邹昊靖,周红红,李琳,赵丫卉,门玉
关键词:
微小囊泡miRNAC06_食管肿瘤放疗敏感性DNA损伤反应
结项摘要

Radioresistance poses a major clinical challenge in esophageal cancer treatment, but the molecular mechanisms of radioresistant remain unclear. miRNAs were involved in DNA damage response (DDR), but most, if not all, human tumors exhibit defects in the DDR and deregulated miRNA expression. Genotoxic agents including UV, X-irradiation, oxidative stress and chemical mutagens, result in a global change on miRNAs expression in a variety of cell types. However, there is no obvious overlap of DNA damage-induced miRNA profiles, suggesting these DNA damage-responsive miRNAs might be cell type-specific. Previous showed that overexpression of miR-200c induces chemoresistant in esophageal cancers mediated through activation of the Akt signaling pathway. Moreover, Let-7c directly repressed cisplatin-activated interleukin (IL)-6/STAT3 prosurvival pathway. But, the regulatory mechanisms of miRNAs in radiosensitivity of esophageal cancer remain elusive. In this study, we established radioresistant esophageal cancer cell lines and used array analysis to compare levels of different miRNAs between radioresistant cell lines and the parental cell lines from which they were derived. The functional miRNAs were determined by multiple studies in cell culture, animal models and in clinical studies. Moreover, a comprehensive model including serum or tissue miRNAs and the prognosis related clinical factors will be established to predict the radiosensitivity. We further explore that the molecular mechanisms of miRNAs regulating radiosensitivity of human esophageal cancer in vitro and in vivo. This study, focusing on the role of miRNA in regulating tumor radiosensitivity, might be improved the individualized therapy, and provided radiosensitive factors and the prognostic molecules that might potentially guide radiotherapy.

食管癌放疗抵抗是临床面临的一个挑战,然而具体的分子机制还不清楚。研究表明miRNAs参与DNA损伤反应(DDR),但大多数肿瘤都存在DDR缺陷及miRNAs表达的下调,DDR相关miRNAs表达不仅依赖基因组的稳定性,而且还依赖肿瘤组织及病理类型。在食管癌中,miR-200c、Let-7c与食管癌化疗敏感性相关,然而关于miRNAs与食管癌放疗敏感性尚缺乏系统的阐述。本课题拟从食管癌耐放射细胞模型入手,利用miRNAs芯片筛选与食管癌放疗敏感性相关的miRNAs,然后通过细胞水平、临床标本及动物水平三个不同层面研究miRNAs与食管癌放疗敏感性的关系,确定特定功能性miRNAs, 建立预测放疗疗效的miRNAs模型;在DNA损伤反应中,通过对miRNAs靶基因及其转录调控的研究,深入阐述miRNAs调节食管癌放疗敏感性的分子机制,为临床评判食管癌放疗疗效及个体化治疗提供新的靶点。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis

A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis

DOI:10.3390/cancers13174258
发表时间:2021
2

针灸治疗胃食管反流病的研究进展

针灸治疗胃食管反流病的研究进展

DOI:
发表时间:2022
3

坚果破壳取仁与包装生产线控制系统设计

坚果破壳取仁与包装生产线控制系统设计

DOI:10.19554/j.cnki.1001-3563.2018.21.004
发表时间:2018
4

MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human Body

MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human Body

DOI:10.3389
发表时间:2021
5

敏感性水利工程社会稳定风险演化SD模型

敏感性水利工程社会稳定风险演化SD模型

DOI:10.16265/j.cnki.issn1003-3033.2021.04.003
发表时间:2021

骆爱萍的其他基金

批准号:81872476
批准年份:2018
资助金额:57.00
项目类别:面上项目
批准号:81101740
批准年份:2011
资助金额:22.00
项目类别:青年科学基金项目

相似国自然基金

1

宫颈癌放疗敏感性microRNA预测模型的建立及调节机制研究

批准号:81072128
批准年份:2010
负责人:吴小华
学科分类:H1813
资助金额:36.00
项目类别:面上项目
2

MnSOD在食管鳞癌发生中的作用及双向调节食管癌放疗敏感性的分子机制研究

批准号:81402534
批准年份:2014
负责人:孙国贵
学科分类:H1821
资助金额:23.00
项目类别:青年科学基金项目
3

胃癌患者铂类及紫杉类药物疗效分子预测模型的建立及验证

批准号:81370064
批准年份:2013
负责人:魏嘉
学科分类:H1814
资助金额:70.00
项目类别:面上项目
4

Brd4A调节DNA损伤应答影响食管癌放疗敏感性的机制研究

批准号:81874220
批准年份:2018
负责人:赵磊
学科分类:H1821
资助金额:53.00
项目类别:面上项目